Literature DB >> 9526861

Detection of human granulocytic ehrlichiosis agent and Borrelia burgdorferi in ticks by polymerase chain reaction.

Y F Chang1, V Novosel, C F Chang, J B Kim, S J Shin, D H Lein.   

Abstract

Adult ixodid ticks were collected from Westchester County, New York, and Ipswich, Massachusetts, to determine the presence of infection with a human granulocytic ehrlichiosis (HGE) agent by using the polymerase chain reaction (PCR). The presence of Borrelia burgdorferi in ticks collected from New York was also determined by PCR. Of the 229 ticks from New York and 47 ticks from Massachusetts, 9% (22/229) and 25% (12/47) of ticks contained HGE agent, respectively. Fifty-four percent (123/229) of the ticks collected from New York were B. burgdorferi positive; 4% (9/229) of these ticks contained both HGE agent and B. burgdorferi. This finding indicates that animals with Lyme borreliosis may be also exposed to the etiologic agent of HGE. More extensive laboratory diagnosis may be necessary when multiple tick-borne diseases are suspected in animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9526861     DOI: 10.1177/104063879801000110

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  12 in total

Review 1.  Molecular detection of pathogen DNA in ticks (Acari: Ixodidae): a review.

Authors:  O A Sparagano; M T Allsopp; R A Mank; S G Rijpkema; J V Figueroa; F Jongejan
Journal:  Exp Appl Acarol       Date:  1999-12       Impact factor: 2.132

2.  Human granulocytic ehrlichiosis agent infection in a pony vaccinated with a Borrelia burgdorferi recombinant OspA vaccine and challenged by exposure to naturally infected ticks.

Authors:  Y F Chang; S P McDonough; C F Chang; K S Shin; W Yen; T Divers
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

3.  Identification of Ehrlichia spp. and Borrelia burgdorferi in Ixodes ticks in the Baltic regions of Russia.

Authors:  A N Alekseev; H V Dubinina; I Van De Pol; L M Schouls
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

4.  Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis.

Authors:  V Thomas; J Anguita; S W Barthold; E Fikrig
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Infection with agents of human granulocytic ehrlichiosis, lyme disease, and babesiosis in wild white-footed mice (Peromyscus leucopus) in Connecticut.

Authors:  K C Stafford; R F Massung; L A Magnarelli; J W Ijdo; J F Anderson
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

6.  Invasion and intracellular development of the human granulocytic ehrlichiosis agent in tick cell culture.

Authors:  U G Munderloh; S D Jauron; V Fingerle; L Leitritz; S F Hayes; J M Hautman; C M Nelson; B W Huberty; T J Kurtti; G G Ahlstrand; B Greig; M A Mellencamp; J L Goodman
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

7.  Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent.

Authors:  Craig A Jackson; Steven D Lovrich; William A Agger; Steven M Callister
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

8.  Multiplex detection of Ehrlichia and Anaplasma species pathogens in peripheral blood by real-time reverse transcriptase-polymerase chain reaction.

Authors:  Kamesh R Sirigireddy; Roman R Ganta
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

9.  Body lice as tools for diagnosis and surveillance of reemerging diseases.

Authors:  V Roux; D Raoult
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

10.  PCR detection of Borrelia burgdorferi sensu lato, tick-borne encephalitis virus, and the human granulocytic ehrlichiosis agent in Ixodes persulcatus ticks from Western Siberia, Russia.

Authors:  Olga V Morozova; Andrey K Dobrotvorsky; Natalya N Livanova; Sergey E Tkachev; Valentina N Bakhvalova; Anatoly B Beklemishev; Felipe C Cabello
Journal:  J Clin Microbiol       Date:  2002-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.